Clara studied Pharmacy at the University of Kiel, Germany, from 2007 to 2011. In 2012, she completed her practical training working as a pharmacist for Boehringer Ingelheim in Biberach an der Riss, Germany, with a focus on formulation development. She is a licensed pharmacist in Germany.
From 2013 to 2017, she obtained a PhD in Pharmacy from the University of Bonn, Germany. Her dissertation focused on small molecule ligand discovery for understudied G protein-coupled receptors, by using high-throughput screening methods, followed by in-depth pharmacological characterization and classical hit-to-lead approaches. As part of her thesis work, she spent three months at Vanderbilt University to study computational methods for ligand discovery in the lab of Jens Meiler.
In 2018, she joined the Meiler and the Crowe labs in a collaborative project on vaccine and antibody development as a post-doctoral fellow. Her work comprises of computational aspects as epitope-focused immunogen design as well as the experimental screening and characterization of immunogen candidates. She is particularly interested in understanding the immune response to Ebola, and Marburg.